Atlas Trials

Construction of a Prognostic and Prediction Model for Perioperative Immunotherapy in NSCLC: A Multi - Omics Perspective

Clinical trial NCT06856798 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06856798
Sponsor
Ziming Li
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
NSCLC Stage IIIA/BNSCLC Stage II
Start date
2025-03-10
Primary completion
2026-03-09
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.